Wells Fargo’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $109K | Sell |
118,752
-228,968
| -66% | -$277K | ﹤0.01% | 5062 |
|
|
2025
Q4 | $445K | Buy |
347,720
+104,758
| +43% | +$141K | ﹤0.01% | 4577 |
|
|
2025
Q3 | $316K | Buy |
242,962
+37,427
| +18% | +$49K | ﹤0.01% | 4647 |
|
|
2025
Q2 | $247K | Buy |
205,535
+22,640
| +12% | +$25.1K | ﹤0.01% | 4647 |
|
|
2025
Q1 | $198K | Buy |
182,895
+1,639
| +0.9% | +$2.3K | ﹤0.01% | 4712 |
|
|
2024
Q4 | $317K | Buy |
181,256
+40,894
| +29% | +$76.2K | ﹤0.01% | 4482 |
|
|
2024
Q3 | $271K | Buy |
140,362
+6,831
| +5% | +$13.4K | ﹤0.01% | 4380 |
|
|
2024
Q2 | $236K | Buy |
133,531
+122,324
| +1,091% | +$299K | ﹤0.01% | 4409 |
|
|
2024
Q1 | $30.4K | Buy |
11,207
+10,221
| +1,037% | +$24.7K | ﹤0.01% | 5445 |
|
|
2023
Q4 | $2.18K | Buy |
986
+39
| +4% | +$83 | ﹤0.01% | 6094 |
|
|
2023
Q3 | $2.75K | Buy |
947
+64
| +7% | +$167 | ﹤0.01% | 6048 |
|
|
2023
Q2 | $1.7K | Buy |
883
+15
| +2% | +$30 | ﹤0.01% | 6240 |
|
|
2023
Q1 | $1.69K | Buy |
868
+7
| +0.8% | +$14 | ﹤0.01% | 6256 |
|
|
2022
Q4 | $1.01K | Buy |
861
+16
| +2% | +$20 | ﹤0.01% | 6184 |
|
|
2022
Q3 | $1K | Sell |
845
-1,185
| -58% | -$1.79K | ﹤0.01% | 6380 |
|
|
2022
Q2 | $3K | Sell |
2,030
-15,228
| -88% | -$37.7K | ﹤0.01% | 6189 |
|
|
2022
Q1 | $62K | Sell |
17,258
-28,513
| -62% | -$98.5K | ﹤0.01% | 5549 |
|
|
2021
Q4 | $179K | Sell |
45,771
-99,847
| -69% | -$467K | ﹤0.01% | 5327 |
|
|
2021
Q3 | $960K | Buy |
145,618
+111,882
| +332% | +$736K | ﹤0.01% | 4276 |
|
|
2021
Q2 | $208K | Sell |
33,736
-45,775
| -58% | -$245K | ﹤0.01% | 5014 |
|
|
2021
Q1 | $359K | Sell |
79,511
-102,198
| -56% | -$561K | ﹤0.01% | 4870 |
|
|
2020
Q4 | $1.09M | Buy |
181,709
+105,463
| +138% | +$693K | ﹤0.01% | 3968 |
|
|
2020
Q3 | $566K | Sell |
76,246
-18,836
| -20% | -$130K | ﹤0.01% | 4251 |
|
|
2020
Q2 | $381K | Sell |
95,082
-32,840
| -26% | -$114K | ﹤0.01% | 4513 |
|
|
2020
Q1 | $325K | Buy |
127,922
+9,043
| +8% | +$29.7K | ﹤0.01% | 4363 |
|
|
2019
Q4 | $413K | Sell |
118,879
-122,002
| -51% | -$429K | ﹤0.01% | 4520 |
|
|
2019
Q3 | $1.12M | Sell |
240,881
-96,709
| -29% | -$762K | ﹤0.01% | 3756 |
|
|
2019
Q2 | $4.16M | Buy |
337,590
+99,137
| +42% | +$1.26M | ﹤0.01% | 2731 |
|
|
2019
Q1 | $3.17M | Buy |
238,453
+211,926
| +799% | +$2.23M | ﹤0.01% | 2971 |
|
|
2018
Q4 | $229K | Sell |
26,527
-23,343
| -47% | -$182K | ﹤0.01% | 4830 |
|
|
2018
Q3 | $374K | Buy |
49,870
+953
| +2% | +$6.78K | ﹤0.01% | 4637 |
|
|
2018
Q2 | $292K | Buy |
48,917
+19,972
| +69% | +$114K | ﹤0.01% | 4820 |
|
|
2018
Q1 | $169K | Buy |
28,945
+11,377
| +65% | +$74.7K | ﹤0.01% | 5061 |
|
|
2017
Q4 | $103K | Sell |
17,568
-4,574
| -21% | -$25K | ﹤0.01% | 5291 |
|
|
2017
Q3 | $111K | Buy |
22,142
+2,009
| +10% | +$8.45K | ﹤0.01% | 5192 |
|
|
2017
Q2 | $81K | Sell |
20,133
-5,388
| -21% | -$25.5K | ﹤0.01% | 5255 |
|
|
2017
Q1 | $146K | Buy |
25,521
+3,327
| +15% | +$21.1K | ﹤0.01% | 5002 |
|
|
2016
Q4 | $162K | Buy |
22,194
+9,894
| +80% | +$62.1K | ﹤0.01% | 4878 |
|
|
2016
Q3 | $98K | Sell |
12,300
-1,615
| -12% | -$14.8K | ﹤0.01% | 4923 |
|
|
2016
Q2 | $126K | Sell |
13,915
-1,819
| -12% | -$17.1K | ﹤0.01% | 4678 |
|
|
2016
Q1 | $127K | Buy |
15,734
+2,707
| +21% | +$19.5K | ﹤0.01% | 4677 |
|
|
2015
Q4 | $141K | Sell |
13,027
-1,523
| -10% | -$15K | ﹤0.01% | 4686 |
|
|
2015
Q3 | $118K | Sell |
14,550
-7,239
| -33% | -$114K | ﹤0.01% | 4774 |
|
|
2015
Q2 | $527K | Buy |
21,789
+12,716
| +140% | +$401K | ﹤0.01% | 4057 |
|
|
2015
Q1 | $382K | Buy |
9,073
+3,500
| +63% | +$138K | ﹤0.01% | 4103 |
|
|
2014
Q4 | $188K | Sell |
5,573
-27,186
| -83% | -$770K | ﹤0.01% | 4460 |
|
|
2014
Q3 | $803K | Buy |
32,759
+20,092
| +159% | +$565K | ﹤0.01% | 3618 |
|
|
2014
Q2 | $372K | Sell |
12,667
-14,387
| -53% | -$461K | ﹤0.01% | 4064 |
|
|
2014
Q1 | $1.19M | Buy |
27,054
+6,227
| +30% | +$274K | ﹤0.01% | 3365 |
|
|
2013
Q4 | $798K | Sell |
20,827
-168,296
| -89% | -$4.96M | ﹤0.01% | 3554 |
|
|
2013
Q3 | $4.15M | Sell |
189,123
-12,987
| -6% | -$255K | ﹤0.01% | 2325 |
|
|
2013
Q2 | $3.53M | Buy |
+202,110
| New | +$3.55M | ﹤0.01% | 2385 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Wells Fargo's LAB Position: Q1 2026 in Review
Wells Fargo reduced its Standard BioTools (LAB) stake by 66% in Q1 2026, selling an estimated $277K and leaving 118,752 shares worth $109K. The position accounts for ﹤0.01% of the portfolio, ranked #5062.
Wells Fargo first reported a position in LAB in Q2 2013 and has held it in 52 quarters since. The position peaked at $4.16M in Q2 2019. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Wells Fargo held 118,752 shares of Standard BioTools worth $109K as of Q1 2026.
- Wells Fargo sold 228,968 Standard BioTools shares in Q1 2026, an estimated $277K.
- Standard BioTools made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #5062 holding.
- Wells Fargo first reported a position in Standard BioTools in Q2 2013 and has held it in 52 quarters since.
- Wells Fargo's Standard BioTools position peaked at $4.16M in Q2 2019.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.